At @-year follow-up , rates of major adverse cardiac events were similar in patients treated with both types of stents ( zotarolimus-eluting stents @/@ -LSB- @ % -RSB- vs sirolimus-eluting stents @/@ -LSB- @ % -RSB- ; odds ratio -LSB- OR -RSB- @ , @ % CI @-@ @ ; p = @ ) .